PharmaCCX announces Sean Tunis joining as member of Advisory Board

October 25, 2021

PharmaCCX continues to add experts in the field to their Advisory Board. Today they are excited to announce the addition of Sean Tunis, MD, MSc. to the Advisory Board. Sean's expertise in evaluating the value of treatments and reimbursement strategies will inform the company's strategy moving forward.

"I have really enjoyed the conversations I've had with Sean and the collaborators he's been encouraging me to speak with" said Nathan Sigworth, CEO of PharmaCCX. "His deep expertise and practical intuition, not to mention his personal network, will add significant value to our team as we navigate and continue to build our bsuiness globally and increase access for patients."

Dr. Tunis is currently a Principal at Rubix Health where he consults with public and private sector organizations on health technology issues at the interface of regulatory and reimbursement policy, market access, comparative effectiveness, outcomes measurement and health technology assessment. He is also a Senior Fellow in the Tufts Center for the Evaluation of Value and Risk in Health. Dr. Tunis also serves as a Mentor-in-Residence at Johns Hopkins Tech Ventures, helping early stage companies to develop their initial reimbursement strategy and to align their clinical development programs with payer and regulatory requirements.

"There are many opportunities to discuss challenges to getting new therapies to patients and potential solutions in theory. At PharmaCCX we have an opportunity to actually put this into practice. CCX is building the infrastructure to deliver patient access to new therapies, and I am excited to be a part of that." Sean Tunis commented.

Beyond his work at Rubix Health Sean has served as a Senior Advisor in the Office of the Principal Deputy Commissioner at the FDA, he founded the Center for Medical Technology in Baltimore, MD, and held several positions at the Centers for Medicare and Medicaid Services (CMS) including Director of the Office of Clinical Standards and Quality and as Chief Medical Officer. Prior to joining CMS he was a research scientist at Technology Assessment Group, was Director of the Health Program at the Congressional Office of Technology Assessment and was an advisor to the US Senate Committee on Labor and Human Resources.

Dr. Tunis received a B.S. degree in Biology and History of Science from the Cornell University School of Agriculture, and a medical degree and master’s in health services research from the Stanford University School of Medicine. Dr. Tunis did his residency training at UCLA and the University of Maryland in Emergency Medicine and Internal Medicine. He is board certified in Internal Medicine and holds adjunct faculty appointments at Johns Hopkins and Tufts.

CCX is building the infrastructure to deliver patient access to new therapies, and I am excited to be a part of that